LBRX
Price:
$19.25
Market Cap:
$487.01M
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.
Industry
Biotechnology
IPO Date
2025-09-11
Stock Exchange
NASDAQ
Ticker
LBRX
According to LB Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current ROE is 97.81%. This represents a change of 816.35% compared to the average of 10.67% of the last 4 quarters.
The mean historical ROE of LB Pharmaceuticals Inc Common Stock over the last ten years is 44.91%. The current 97.81% ROE has changed 117.78% with respect to the historical average. Over the past ten years (40 quarters), LBRX's ROE was at its highest in in the March 2024 quarter at 32.02%. The ROE was at its lowest in in the June 2024 quarter at 0%.
Average
44.91%
Median
49.80%
Minimum
18.20%
Maximum
66.74%
Discovering the peaks and valleys of LB Pharmaceuticals Inc Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.63%
Maximum Annual ROE = 66.74%
Minimum Annual Increase = -63.45%
Minimum Annual ROE = 18.20%
| Year | ROE | Change |
|---|---|---|
| 2024 | 66.74% | 266.63% |
| 2023 | 18.20% | -63.45% |
The current ROE of LB Pharmaceuticals Inc Common Stock (LBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.91%
5-year avg
44.91%
10-year avg
44.91%
LB Pharmaceuticals Inc Common Stock’s ROE is greater than Rocket Pharmaceuticals, Inc. (-62.44%), greater than Aura Biosciences, Inc. (-64.45%), greater than Annexon, Inc. (-70.04%), greater than Solid Biosciences Inc. (-73.63%), greater than Larimar Therapeutics, Inc. (-62.92%), greater than Altimmune, Inc. (-54.79%), greater than Autolus Therapeutics plc (-56.18%), greater than DBV Technologies S.A. (-287.15%), greater than Design Therapeutics, Inc. (-27.15%), greater than Korro Bio, Inc. (-61.51%),
| Company | ROE | Market cap |
|---|---|---|
| -62.44% | $370.12M | |
| -64.45% | $409.59M | |
| -70.04% | $536.98M | |
| -73.63% | $461.22M | |
| -62.92% | $314.97M | |
| -54.79% | $468.65M | |
| -56.18% | $417.84M | |
| -287.15% | $312.18M | |
| -27.15% | $559.35M | |
| -61.51% | $63.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LB Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LB Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LB Pharmaceuticals Inc Common Stock's ROE?
How is the ROE calculated for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the highest ROE for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the 3-year average ROE for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the 5-year average ROE for LB Pharmaceuticals Inc Common Stock (LBRX)?
How does the current ROE for LB Pharmaceuticals Inc Common Stock (LBRX) compare to its historical average?